Does EQUINE THYMOCYTE IMMUNE GLOBULIN Cause Product use issue? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Product use issue have been filed in association with EQUINE THYMOCYTE IMMUNE GLOBULIN (Lymphocytes 6X). This represents 4.7% of all adverse event reports for EQUINE THYMOCYTE IMMUNE GLOBULIN.
36
Reports of Product use issue with EQUINE THYMOCYTE IMMUNE GLOBULIN
4.7%
of all EQUINE THYMOCYTE IMMUNE GLOBULIN reports
4
Deaths
3
Hospitalizations
How Dangerous Is Product use issue From EQUINE THYMOCYTE IMMUNE GLOBULIN?
Of the 36 reports, 4 (11.1%) resulted in death, 3 (8.3%) required hospitalization, and 24 (66.7%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EQUINE THYMOCYTE IMMUNE GLOBULIN. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does EQUINE THYMOCYTE IMMUNE GLOBULIN Cause?
Transplant rejection (100)
Alopecia (98)
Acne (97)
Transplant dysfunction (97)
Ovarian cyst (96)
Drug ineffective (89)
Pyrexia (69)
Acute kidney injury (58)
Condition aggravated (55)
Product use in unapproved indication (55)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which EQUINE THYMOCYTE IMMUNE GLOBULIN Alternatives Have Lower Product use issue Risk?
EQUINE THYMOCYTE IMMUNE GLOBULIN vs ERAVACYCLINE
EQUINE THYMOCYTE IMMUNE GLOBULIN vs ERBITUX
EQUINE THYMOCYTE IMMUNE GLOBULIN vs ERDAFITINIB
EQUINE THYMOCYTE IMMUNE GLOBULIN vs ERENUMAB
EQUINE THYMOCYTE IMMUNE GLOBULIN vs ERENUMAB-AOOE